This inventor holds 1 USPTO granted patent. Top assignee: Rorer Pharmaceutical Corporation. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Tihamer Herczeg: Innovator in Enhanced Oxygen Availability
Introduction
Tihamer Herczeg is a notable inventor based in Perkiomenville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in enhancing oxygen availability to mammalian tissue. His innovative work has led to the development of a unique patent that addresses critical medical conditions.
Latest Patents
Herczeg holds a patent for the treatment of conditions requiring enhanced oxygen availability. The patent discloses pharmaceutical compositions containing certain heterocyclic sulphonamido azo compounds. These compounds are designed to improve oxygen availability to mammalian tissue, showcasing Herczeg's commitment to advancing medical science. He has 1 patent to his name.
Career Highlights
Tihamer Herczeg is associated with Rorer Pharmaceutical Corporation, where he has been able to apply his expertise in pharmaceutical development. His work at the company has allowed him to focus on innovative solutions that address significant health challenges.
Collaborations
Herczeg has collaborated with notable colleagues, including Robert G Pendleton and Charles E Pendley, II. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Tihamer Herczeg is a dedicated inventor whose work in enhancing oxygen availability has the potential to impact medical treatments significantly. His contributions to the pharmaceutical field exemplify the importance of innovation in addressing health-related challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile